Login to Your Account

Nicox acquires Aciex in stock deal: $65M up front, $55M contingent payments

By Cormac Sheridan
Staff Writer

Wednesday, July 2, 2014
Nicox SA is paying $65 million up front and could pay up to $55 million more in a cash-free, stock-based acquisition of Aciex Therapeutics Inc. that gives it a near-term shot at a product approval.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription